Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells
Open accessAbstract
Background PU.1 is a hematopoietic cell-specific transcription factor belonging to the Ets family. We hypothesized that PU.1 is involved in MHC class II expression in dendritic cells (DCs). Objective The role of PU.1 in MHC class II expression in DCs was analyzed. Methods Transcriptional regulation of the DC-specific pI promoter of the class II transactivator (CIITA) gene and subsequent MHC class II expression was investigated by using PU.1 small interfering RNA (siRNA) and reporter, chromatin immunoprecipitation, and electrophoretic mobility shift assays. Results PU.1 siRNA introduction suppressed MHC class II expression, allogeneic and syngeneic T-cell activation activities of bone marrow-derived DCs (BMDCs) with reduction of CIITA mRNA driven by the DC-specific promoter pI, and MHC class II mRNA. The chromatin immunoprecipitation assay showed constitutive binding of PU.1 to the pI region in BMDCs, whereas acetylation of histone H3 on pI was suppressed by LPS stimulation in parallel with shutdown of CIITA transcription. PU.1 transactivated the pI promoter through cis-elements at -47/-44 and -30/-27 in a reporter assay and to which PU.1 directly bound in an electrophoretic mobility shift assay. Acetylation of histones H3 and H4 on pI was reduced in PU.1 siRNA-introduced BMDCs. Knockdown of interferon regulatory factor 4 or 8, which is a heterodimer partner of PU.1, by siRNA did not affect pI-driven CIITA transcription or MHC class II expression. Conclusion PU.1 basally transactivates the CIITA pI promoter in DCs by functioning as a monomeric transcription factor and by affecting histone modification, resulting in the subsequent expression and function of MHC class II.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
PU.1 regulates numerous gene programs associated with host defense and immune function, including expression of MHC and costimulatory genes, as well as immune checkpoints and immune effector genes.
“PU.1 regulates numerous gene programs associated with host defense and immune function, including expression of MHC and costimulatory genes, as well as immune checkpoints and immune effector genes (Fisher et al., 1998; Karpurapu et al., 2011; Kitamura et al., 2012; Keightley et al., 2017).”
From PU.1 is required to restrain myelopoiesis during chronic inflammatory stress (2023) · cites this paper as Kitamura et al., 2012
The paper’s Abstract (page not provided) reports that PU.1 regulates CIITA pI and subsequent MHC class II expression in dendritic cells. It also describes prior work identifying PU.1 as a regulator of the costimulatory genes CD80 and CD86. Our copy does not support attributing regulation of immune checkpoint or immune effector genes to this paper. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Lutz, M. B., Kukutsch, N. A., Ogilvie, A. L. J., Rößner, S., Koch, F., Romani, N., & Schuler, G. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00204-x · Cited by 2,972 · see citing works
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532 · see citing works
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130 · see citing works
Chang, H.-C., Sehra, S., Goswami, R., Yao, W., Yu, Q., Stritesky, G. L., Jabeen, R., McKinley, C., Ahyi, A.-N., Han, L., et al. (2010) · Nature Immunology · doi:10.1038/ni.1867 · Cited by 577 · see citing works
Mühlethaler‐Mottet, A., Otten, L., Steimle, V., & Mach, B. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2851 · Cited by 507 · see citing works
Regulation of MHC class II gene expression by the class II transactivator
Reith, W., LeibundGut‐Landmann, S., & Waldburger, J. (2005) · Nature reviews. Immunology · doi:10.1038/nri1708 · Cited by 463 · see citing works
Mühlethaler‐Mottet, A., Berardino, W. D., Otten, L., & Mach, B. (1998) · Immunity · doi:10.1016/s1074-7613(00)80468-9 · Cited by 376 · see citing works
Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors
Nutt, S. L., Metcalf, D., D'Amico, A., Polli, M., & Wu, L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041535 · Cited by 325 · see citing works
Carotta, S., Dakic, A., D'Amico, A., Pang, S. H. M., Greig, K. T., Nutt, S. L., & Wu, L. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.005 · Cited by 279 · see citing works
Scott, E. W., Fisher, R. C., Olson, M. C., Kehrli, E. W., Simon, M. C., & Singh, H. (1997) · Immunity · doi:10.1016/s1074-7613(00)80287-3 · Cited by 270 · see citing works
PU. 1 is required for myeloid-derived but not lymphoid-derived dendritic cells
Guerriero, A., Langmuir, P. B., Spain, L. M., & Scott, E. W. (2000) · Blood · doi:10.1182/blood.v95.3.879.003k13_879_885 · Cited by 190 · see citing works
LeibundGut‐Landmann, S., Mühlethaler‐Mottet, A., Bernasconi, L., Suter, T. B., Waldburger, J., Masternak, K., Arrighi, J.-F., Hauser, C., Fontana, A., & Reith, W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.379 · Cited by 165 · see citing works
Anderson, K. L., Perkin, H. B., Surh, C. D., Venturini, S., Maki, R. A., & Torbett, B. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1855 · Cited by 159 · see citing works
Crystal structure of PU. 1/IRF-4/DNA ternary complex
Escalante, C. R., Brass, A. L., Pongubala, J. M. R., Shatova, E., Shen, L., Singh, H., & Aggarwal, A. K. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00703-7 · Cited by 154 · see citing works
Holling, T. M., van der Stoep, N., Quinten, E., & van den Elsen, P. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.763 · Cited by 149 · see citing works
MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells
LeibundGut‐Landmann, S., Waldburger, J., Sousa, C. R. E., Acha‐Orbea, H., & Reith, W. (2004) · Nature Immunology · doi:10.1038/ni1109 · Cited by 149 · see citing works
Regulation of Class II MHC Expression in APCs: Roles of Types I, III, and IV Class II Transactivator
Pai, R. K., Askew, D. S., Boom, W. H., & Harding, C. V. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1326 · Cited by 107 · see citing works
Nishiyama, C., Yokota, T., Okumura, K., & Ra, C. (1999) · PubMed · Cited by 77 · see citing works
Self-citationRegulation of Human FcεRI α-Chain Gene Expression by Multiple Transcription Factors
Nishiyama, C., Hasegawa, M., Nishiyama, M., Takahashi, K., Akizawa, Y., Yokota, T., Okumura, K., Ogawa, H., & Ra, C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4546 · Cited by 75 · see citing works
Self-citationCritical Role of Transcription Factor PU.1 in the Expression of CD80 and CD86 on Dendritic Cells
Kanada, S., Nishiyama, C., Nakano, N., Suzuki, R., Maeda, K., Hara, M., Kitamura, N., Ogawa, H., & Okumura, K. (2011) · Blood · doi:10.1182/blood-2010-06-291898 · Cited by 73 · see citing works
Self-citationIs PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis?
Dakic, A., Wu, L., & Nutt, S. L. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.006 · Cited by 72 · see citing works
Nishiyama, C., Yokota, T., Okumura, K., & Ra, C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.623 · Cited by 70 · see citing works
Self-citationNakano, N., Nishiyama, C., Kanada, S., Niwa, Y., Shimokawa, N., Ushio, H., Nishiyama, M., Okumura, K., & Ogawa, H. (2007) · Blood · doi:10.1182/blood-2006-09-045641 · Cited by 69 · see citing works
Self-citationNotch signaling confers antigen-presenting cell functions on mast cells
Nakano, N., Nishiyama, C., Yagita∥, H., Koyanagi, A., Akiba, H., Chiba, S., Ogawa, H., & Okumura, K. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.10.040 · Cited by 68 · see citing works
Self-citationSmith, M. A., Wright, G. M., Wu, J., Tailor, P. B., Ozato, K., Chen, X., Wei, S., Piskurich, J. F., Ting, J. P. ‐., & Wright, K. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.165431 · Cited by 63 · see citing works
Maeda, K., Nishiyama, C., Tokura, T., Nakano, H., Kanada, S., Nishiyama, M., Okumura, K., & Ogawa, H. (2006) · Blood · doi:10.1182/blood-2005-07-2878 · Cited by 60 · see citing works
Self-citationNishiyama, C., Akizawa, Y., Nishiyama, M., Tokura, T., Kawada, H., Mitsuishi, K., Hasegawa, M., Ito, T., Nakano, N., Okamoto, A., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6458 · Cited by 60 · see citing works
Self-citationvan der Stoep, N., Quinten, E., Rezende, M. M., & van den Elsen, P. J. (2004) · Blood · doi:10.1182/blood-2004-03-0790 · Cited by 56 · see citing works
Walseng, E., Furuta, K., Goldszmid, R. S., Weih, K. A., Sher, A., & Roche, P. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.157586 · Cited by 55 · see citing works
Maeda, K., Nishiyama, C., Tokura, T., Akizawa, Y., Nishiyama, M., Ogawa, H., Okumura, K., & Ra, C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.334 · Cited by 52 · see citing works
Self-citationHamdorf, M., Berger, A., Schüle, S., Reinhardt, J., & Flory, E. (2011) · Stem Cells · doi:10.1002/stem.564 · Cited by 45 · see citing works
Kanada, S., Nakano, N., Potaczek, D. P., Maeda, K., Shimokawa, N., Niwa, Y., Fukai, T., Sanak, M., Szczeklik, A., Yagita∥, H., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.8204 · Cited by 45 · see citing works
Self-citationEpigenetic Regulation during B Cell Differentiation Controls CIITA Promoter Accessibility
Green, M. R., Yoon, H., & Boss, J. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3865 · Cited by 37 · see citing works
PU.1 Binds to a Distal Regulatory Element That Is Necessary for B Cell-Specific Expression of CIITA
Yoon, H., & Boss, J. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000079 · Cited by 29 · see citing works
Nishiyama, C., Nishiyama, M., Ito, T., Masaki, S., Maeda, K., Masuoka, N., Yamane, H., Kitamura, T., Ogawa, H., & Okumura, K. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.145 · Cited by 25 · see citing works
Self-citationIto, T., Nishiyama, C., Nishiyama, M., Matsuda, H., Maeda, K., Akizawa, Y., Tsuboi, R., Okumura, K., & Ogawa, H. (2005) · Journal of Immunology · doi:10.4049/jimmunol.174.1.376 · Cited by 25 · see citing works
Self-citationIto, T., Nishiyama, C., Nakano, N., Nishiyama, M., Usui, Y., Takeda, K., Kanada, S., Fukuyama, K., Akiba, H., Tokura, T., et al. (2009) · International Immunology · doi:10.1093/intimm/dxp048 · Cited by 23 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- REFERENCES E1. Ito T, Nishiyama C, Nakano N, Nishiyama M, Usui Y, Takeda K, et al. Roles of PU.1 in monocyte-and mast cell-specific gene regulation: PU.1 transactivates CIITA pIV in cooperation with IFN-gamma. Int Immunol 2009;21:803-16.
Cited by
Sorted by citations
Direct reprogramming of fibroblasts into antigen-presenting dendritic cells
Rosa, F. A., Pires, C. F., Kurochkin, I., Ferreira, A. G., Gomes, A. M., Palma, L. G., Shaiv, K., Solanas, L., Azenha, C. D. J., Papatsenko, D., et al. (2018) · Science Immunology · doi:10.1126/sciimmunol.aau4292 · Cited by 119 · see citing works
Lau, S.-F., Chen, C., Fu, W.-Y., Qu, J. Y., Cheung, T. H., Fu, A. K. Y., & Ip, N. Y. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107530 · Cited by 114 · see citing works
Transcription factor PU.1 and immune cell differentiation (Review)
Li, G., Hao, W., & Hu, W. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4763 · Cited by 98 · see citing works
Qian, F., Deng, J., Lee, Y. G., Zhu, J., Karpurapu, M., Chung, S., Zheng, J.-N., Xiao, L., Park, G. Y., & Christman, J. W. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv042 · Cited by 90 · see citing works
Chen, Q., Mang, G., Wu, J., Sun, P., Li, T., Zhang, H., Wang, N., Tong, Z., Wang, W., Zheng, Y., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.07.001 · Cited by 56 · see citing works
GATA2 Is a Critical Transactivator for the Human IL1RL1/ST2 Promoter in Mast Cells/Basophils
Baba, Y., Maeda, K., Yashiro, T., Inage, E., Kasakura, K., Suzuki, R., Niyonsaba, F., Hara, M., Tanabe, A., Ogawa, H., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.374876 · Cited by 54 · see citing works
Self-citationThe Orphan Nuclear Receptor NR4A3 Is Involved in the Function of Dendritic Cells
Nagaoka, M., Yashiro, T., Uchida, Y., Ando, T., Hara, M., Arai, H., Ogawa, H., Okumura, K., Kasakura, K., & Nishiyama, C. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601911 · Cited by 50 · see citing works
Self-citationPU.1 Suppresses Th2 Cytokine Expression via Silencing of GATA3 Transcription in Dendritic Cells
Yashiro, T., Kubo, M., Ogawa, H., Okumura, K., & Nishiyama, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137699 · Cited by 41 · see citing works
Self-citationYashiro, T., Yura, S., Tobita, A., Toyoda, Y., Kasakura, K., & Nishiyama, C. (2020) · The FASEB Journal · doi:10.1096/fj.202001502r · Cited by 38 · see citing works
Self-citationInage, E., Kasakura, K., Yashiro, T., Suzuki, R., Baba, Y., Nakano, N., Hara, M., Tanabe, A., Oboki, K., Matsumoto, K., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302366 · Cited by 35 · see citing works
Self-citationKasakura, K., Nagata, K., Miura, R., Iida, M., Nakaya, H., Okada, H., Arai, T., Arai, T., Kawakami, Y., Kawakami, T., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900094 · Cited by 32 · see citing works
Self-citationETS Transcription Factors in Immune Cells and Immune-Related Diseases
Yang, Y., Han, X., Sun, L., Shao, F., Yin, Y., & Zhang, W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810004 · Cited by 34 · see citing works
Yashiro, T., Yamamoto, M., Araumi, S., Hara, M., Yogo, K., Uchida, K., Kasakura, K., & Nishiyama, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.649572 · Cited by 31 · see citing works
Self-citationA transcription factor PU.1 is critical for Ccl22 gene expression in dendritic cells and macrophages
Yashiro, T., Nakano, S., Nomura, K., Uchida, Y., Kasakura, K., & Nishiyama, C. (2019) · Scientific Reports · doi:10.1038/s41598-018-37894-9 · Cited by 29 · see citing works
Self-citationInvolvement of PU.1 in NFATc1 promoter function in osteoclast development
Ishiyama, K., Yashiro, T., Nakano, N., Kasakura, K., Miura, R., Hara, M., Kawai, F., Maeda, K., Tamura, N., Okumura, K., et al. (2015) · Allergology International · doi:10.1016/j.alit.2015.01.006 · Cited by 28 · see citing works
Self-citationYamazaki, S., Nakano, N., Honjo, A., Hara, M., Maeda, K., Nishiyama, C., Kitaura, J., Ohtsuka, Y., Okumura, K., Ogawa, H., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402856 · Cited by 27 · see citing works
Self-citationThe Transcription Factors PU.1 and IRF4 Determine Dendritic Cell–Specific Expression of RALDH2
Yashiro, T., Yamaguchi, M., Watanuki, Y., Kasakura, K., & Nishiyama, C. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800492 · Cited by 27 · see citing works
Self-citationYashiro, T., Hara, M., Ogawa, H., Okumura, K., & Nishiyama, C. (2016) · Scientific Reports · doi:10.1038/srep34825 · Cited by 25 · see citing works
Self-citationLecoeur, H., Rosazza, T., Kokou, K., Varet, H., Coppée, J., Lari, A., Commère, P., Weil, R., Meng, G., Milon, G., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01098 · Cited by 22 · see citing works
Wolff, L., & Bies, J. (2013) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2013.01.006 · Cited by 21 · see citing works
The effect of PU.1 knockdown on gene expression and function of mast cells
Oda, Y., Kasakura, K., Fujigaki, I., Kageyama, A., Okumura, K., Ogawa, H., Yashiro, T., & Nishiyama, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-19378-y · Cited by 20 · see citing works
Self-citationRole of Ets Proteins in Development, Differentiation, and Function of T‐Cell Subsets
Liu, M., Gao, W., van Velkinburgh, J. C., Wu, Y., Ni, B., & Tian, Y. (2015) · Medicinal Research Reviews · doi:10.1002/med.21361 · Cited by 20 · see citing works
Advances in mechanisms of allergy and clinical immunology in 2012
Bochner, B. S., Rothenberg, M. E., Boyce, J. A., & Finkelman, F. D. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.676 · Cited by 20 · see citing works
Yashiro, T., Takeuchi, H., Nakamura, S., Tanabe, A., Hara, M., Uchida, K., Okumura, K., Kasakura, K., & Nishiyama, C. (2019) · The FASEB Journal · doi:10.1096/fj.201900379rr · Cited by 19 · see citing works
Self-citationIL-33/ST2 Axis: A Potential Therapeutic Target in Neurodegenerative Diseases
Jia, Z., Guo, M., Ge, X., Chen, F., & Lei, P. (2023) · Biomolecules · doi:10.3390/biom13101494 · Cited by 16 · see citing works
Ando, M., Nagata, K., Takeshita, R., Ito, N., Noguchi, S., Minamikawa, N., Kodama, N., Yamamoto, A., Yashiro, T., Hachisu, M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1374425 · Cited by 16 · see citing works
Self-citationBrouwer, M. A. E., Jones‐Warner, W., Rahman, S., Kerstholt, M., Ferreira, A. V., Oosting, M., Hooiveld, G. J. E. J., Netea, M. G., & Joosten, L. A. B. (2020) · Ticks and Tick-borne Diseases · doi:10.1016/j.ttbdis.2020.101611 · Cited by 15 · see citing works
PU.1 is required to restrain myelopoiesis during chronic inflammatory stress
Chavez, J. S., Rabe, J. L., Niño, K. E., Wells, H. H., Gessner, R. L., Mills, T. S., Hernandez, G., & Pietras, E. M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1204160 · Cited by 14 · see citing works
“PU.1 regulates numerous gene programs associated with host defense and immune function, including expression of MHC and costimulatory genes, as well as immune checkpoints and immune effector genes (Fisher et al., 1998; Karpurapu et al., 2011; Kitamura et al., 2012; Keightley et al., 2017).”
BackgroundRole of PU.1 in MHC Class II Expression via CIITA Transcription in Plasmacytoid Dendritic Cells
Miura, R., Kasakura, K., Nakano, N., Hara, M., Maeda, K., Okumura, K., Ogawa, H., Yashiro, T., & Nishiyama, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154094 · Cited by 14 · see citing works
Self-citationThe hematopoietic cell-specific transcription factor PU.1 is critical for expression of CD11c
Yashiro, T., Kasakura, K., Oda, Y., Kitamura, N., Inoue, A., Nakamura, S., Yokoyama, H., Fukuyama, K., Hara, M., Ogawa, H., et al. (2017) · International Immunology · doi:10.1093/intimm/dxx009 · Cited by 14 · see citing works
Self-citationInaba, K., Yashiro, T., Hiroki, I., Watanabe, R., Kasakura, K., & Nishiyama, C. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901008 · Cited by 13 · see citing works
Self-citationXu, X., Gao, X., Zhao, X., Liao, Y., Wu, J., Li, Q., & Li, J. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000438623 · Cited by 12 · see citing works
Takahashi, M., Nagata, K., Watanuki, Y., Yamaguchi, M., Ishii, K., Harada, T., Minamikawa, N., Katagiri, M., Zhao, W., Ito, N., et al. (2024) · Allergy · doi:10.1111/all.16410 · Cited by 13 · see citing works
Self-citationETS-1 in tumor immunology: implications for novel anti-cancer strategies
Wang, S., Wan, L., Zhang, X., Fang, H., Zhang, M., Li, F., & Yan, D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1526368 · Cited by 11 · see citing works
Ito, N., Sakata, F., Hachisu, M., Nagata, K., Ito, T., Nomura, K., Nagaoka, M., Inaba, K., Hara, M., Nakano, N., et al. (2021) · Allergy · doi:10.1111/all.15184 · Cited by 11 · see citing works
Self-citationMajumder, P., Lee, J. T., Barwick, B. G., Patterson, D. G., Bally, A. P. R., Scharer, C. D., & Boss, J. M. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001089 · Cited by 9 · see citing works
Single-cell chromatin accessibility and transcriptomic characterization of Behcet’s disease
Shi, W., Ye, J., Shi, Z., Pan, C., Zhang, Q., Lin, Y., Liang, D., Liu, Y., Lin, X., & Zheng, Y. (2023) · Communications Biology · doi:10.1038/s42003-023-05420-x · Cited by 8 · see citing works
Mizuno, N., & Yanagawa, Y. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174564 · Cited by 7 · see citing works
Salicylaldehyde Suppresses IgE-Mediated Activation of Mast Cells and Ameliorates Anaphylaxis in Mice
Ashikari, T., Hachisu, M., Nagata, K., Ando, D., Iizuka, Y., Ito, N., Ito, K., Ikeda, Y., Matsubara, H., Yashiro, T., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158826 · Cited by 7 · see citing works
Self-citationScheenstra, M. R., Martínez-Botía, P., Acebes‐Huerta, A., Brouwer, R. W. W., Caballero-Sánchez, N., Gillemans, N., Bleser, P. D., Nota, B., Cuyper, I. M. D., Salunkhe, V. A., et al. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.6a1219-711rrr · Cited by 6 · see citing works
Yashiro, T., Sakata, F., Sekimoto, T., Shirai, T., Hasebe, F., Matsuda, K., Kurosawa, S., Suzuki, S., Nagata, K., Kasakura, K., et al. (2019) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2019.1591262 · Cited by 6 · see citing works
Self-citationKodama, N., Okada, H., Hachisu, M., Ando, M., Ito, N., Nagata, K., Katagiri, M., Yasuda, Y., Hiroki, I., Yashiro, T., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1081263 · Cited by 5 · see citing works
Self-citationRole of PU.1 Expression as an Inflammatory Marker in Experimental Autoimmune Uveoretinitis
Umazume, A., Kezuka, T., Matsuda, R., Usui, Y., Takahashi, H., Yamakawa, N., Yashiro, T., Nishiyama, C., & Gotô, H. (2017) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2017.1299867 · Cited by 5 · see citing works
Self-citationMitochondrial metabolism regulates the immunogenic responsiveness of dendritic cells
Heras‐Murillo, I., Mañanes, D., Calafell-Segura, J., García, A. B., Borràs-Eroles, C., Munné, P., Mastrangelo, A., Martínez-Cano, S., Hernansanz‐Agustín, P., Zuriaga, M. A., et al. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.03.012 · Cited by 4 · see citing works
Tojima, R., Nagata, K., Ito, N., Ishii, K., Arai, T., Ito, T., Kasakura, K., & Nishiyama, C. (2024) · FEBS Letters · doi:10.1002/1873-3468.15069 · Cited by 3 · see citing works
Self-citationZhao, W., Nagata, K., Akiyama, R., Yamazaki, Y., Kouda, H., Miura, R., Ishii, K., Tokita, R., Ito, N., Yamasaki, N., et al. (2026) · Allergology International · doi:10.1016/j.alit.2026.05.005 · Cited by 2 · see citing works
Self-citationIshii, K., Nagata, K., Yamashita, N., Yamazaki, Y., Akimoto, Y., Zhao, W., Inoue, M., Ito, N., Kasakura, K., & Nishiyama, C. (2025) · FEBS Journal · doi:10.1111/febs.70252 · Cited by 1 · see citing works
Self-citation(2014) · Receptors & Clinical Investigation · doi:10.14800/rci.98 · Cited by 1 · see citing works
Plasmacytoid Dendritic Cells Are Key Regulators of Immune Tolerance
Matta, B. M. (2012) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1 · see citing works
Transcription factor regulation of T helper subset function
Awe, O. (2015) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1724
The ontogeny of inflammatory macrophages and monocyte-derived dendritic cells
Menezes, S. (2017) · Research Portal (King's College London)
Publications from Juntendo University Graduate School of Medicine, 2012
(2014) · Juntendō Igaku/Juntendo igaku · doi:10.14789/jmj.60.258
Publications from Juntendo University Graduate School of Medicine, 2012 [5/6]
(2015) · Juntendō Igaku/Juntendo igaku · doi:10.14789/jmj.61.84
Katagiri, M., Ito, N., Nagata, K., Nakano, S., Minamikawa, N., Yamashita, N., Takahashi, M., Kurihara, M., Nagaoka, M., Ando, M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.20.581116
Self-citationIshii, K., Nagata, K., Yamashita, N., Yamazaki, Y., Akimoto, Y., Zhao, W., Inoue, M., Ito, N., Kasakura, K., & Nishiyama, C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.10.637371
Self-citationRamani, M., Nguyen, N., Solis, J., Tenen, D. G., & Trinh, B. Q. (2026) · Biology · doi:10.3390/biology15181657
- Authors
- Kitamura, N., Yokoyama, H., Yashiro, T., Nakano, N., Nishiyama, M., Kanada, S., Fukai, T., Hara, M., Ikeda, S., Ogawa, H., Okumura, K., & Nishiyama, C.
- Affiliations
- Juntendo University (JP)
- The University of Tokyo (JP)
- Corresponding author
- Nishiyama, Chiharu
- ORCID
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 129
- Issue
- 3
- Pages
- 814-824.e6
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W1974505259
- Cited by
- 55
- References
- 37
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 1 · 2021: 4 · 2020: 9 · 2019: 3 · 2018: 3 · 2017: 4 · 2016: 3 · 2015: 7 · 2014: 3 · 2013: 2 · 2012: 2
- FWCI
- 0.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Allergy and Clinical Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- PU.1, MHC class II expression, dendritic cells, transcriptional regulation, histone acetylation, histone modifications, ETS transcription factors, IRF4, IRF8, T cell activation, bone marrow-derived dendritic cells, promoter cis-acting elements
- MeSH terms
- Proto-Oncogene Protein Spi-1, Acetylation, Animals, Histocompatibility Antigens Class II, Bone Marrow Cells, Cells, Cultured, Dendritic Cells, Gene Expression Regulation, Histones, Lymphocyte Activation, Mice, Inbred BALB C, Mice, Inbred C57BL, Nuclear Proteins, Promoter Regions, Genetic, Proto-Oncogene Proteins, T-Lymphocytes, Transcriptional Activation, Trans-Activators, RNA, Small Interfering, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review